GNH USA

Europe — EMA

Methotrexaat Accord

GNH USA supplies Methotrexaat Accord (Methotrexate), a antimetabolite for rheumatoid arthritis, psoriasis, and certain cancers.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexaat Accord, is an antimetabolite presented as a sterile injectable solution for intraarterial, intramuscular, intrathecal use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease in appropriate patients.

GNH USA supplies Methotrexaat Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.

What is Methotrexate used for?

Methotrexaat Accord is an antimetabolite used across several disease families, primarily inflammatory and malignant conditions. - Rheumatoid arthritis: reduces joint inflammation and disease activity. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: contributes to remission by inhibiting leukemic cell proliferation. - Osteosarcoma: incorporated into chemotherapy regimens to limit tumor growth. - Gestational trophoblastic disease: promotes resolution of trophoblastic tissue through cytotoxic action.

What are the side effects of Methotrexate?

Methotrexaat Accord may cause a range of adverse reactions.

Common Side Effects: - Nausea and vomiting. - Mucositis and oral ulceration. - Fatigue and lethargy. - Alopecia (hair loss).

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia. - Severe hepatotoxicity with elevated transaminases. - Pulmonary fibrosis or interstitial pneumonitis. - Nephrotoxicity with renal impairment. - Life‑threatening infections. - Anaphylactic or severe hypersensitivity reactions.

What precautions apply to Methotrexate?

Before initiating therapy, several safety measures should be observed. - Liver function monitoring: perform baseline and periodic liver enzyme tests. - Hematologic monitoring: regular complete blood counts to detect marrow suppression. - Renal function assessment: adjust dosing or avoid use in severe renal impairment. - Contraception counseling: advise effective contraception for both sexes during treatment and for a defined period after cessation. - Storage at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Methotrexate interact with?

Methotrexaat Accord can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Concurrent high‑dose NSAIDs: increase risk of renal toxicity and gastrointestinal ulceration. - Other myelosuppressive agents (e.g., cytarabine, cyclophosphamide): may cause profound bone‑marrow depression. - Live vaccines: risk of uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine and other immunosuppressants: enhanced hematologic toxicity. - Sulfonamide antibiotics: may increase methotrexate levels. - Proton‑pump inhibitors: potential alteration of renal clearance. - Trimethoprim‑sulfamethoxazole: additive myelosuppression. - Carbamazepine: may reduce methotrexate efficacy.

Frequently asked questions

What conditions is Methotrexaat Accord used to treat?+
Methotrexaat Accord is indicated for rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease. In each case, the drug works by interfering with cell proliferation or inflammatory pathways, helping to control disease activity and improve clinical outcomes.
How does methotrexate work?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate. Without tetrahydrofolate, cells cannot synthesize purine nucleotides and thymidylate, leading to reduced DNA, RNA, and protein production. This effect is most pronounced in rapidly dividing cells, providing both anti‑inflammatory and anticancer activity.
What determines the dose of Methotrexaat Accord?+
The prescribed dose of Methotrexaat Accord is individualized by the treating physician based on the specific indication, patient weight, renal and hepatic function, and overall treatment plan. No universal dosing schedule is provided; clinicians adjust the regimen to achieve therapeutic goals while minimizing toxicity.
Is methotrexate safe during pregnancy or breastfeeding?+
Methotrexate is generally contraindicated in pregnancy because it can cause fetal malformations and miscarriage. Women of child‑bearing potential should use effective contraception during treatment and for a defined period after stopping. Breastfeeding is also discouraged, as the drug can be excreted in milk and affect the infant.
How do I order Methotrexaat Accord from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.
How does methotrexate compare with other antineoplastic agents?+
Methotrexate belongs to the antimetabolite class, targeting folate metabolism, whereas many other chemotherapeutics act on microtubules, DNA cross‑linking, or kinase inhibition. Compared with agents like cyclophosphamide, methotrexate has a distinct toxicity profile, often causing mucosal and hepatic effects, but it can be effective in cancers that are sensitive to folate pathway disruption.
What are the recommended storage conditions for Methotrexaat Accord?+
Store Methotrexaat Accord at ambient temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from moisture and direct sunlight, and avoid freezing. Follow any additional handling instructions provided on the label to maintain product stability.
How is Methotrexaat Accord administered?+
Methotrexaat Accord is supplied as a sterile injectable solution and is administered by qualified healthcare professionals via intra‑arterial, intramuscular, or intrathecal injection, depending on the clinical indication. The route, dosage, and frequency are determined by the prescriber based on the patient’s condition and response.
What are the most serious risks to watch for while using Methotrexaat Accord?+
The most serious adverse events include bone‑marrow suppression leading to pancytopenia, severe liver injury, pulmonary fibrosis or interstitial pneumonitis, and life‑threatening infections. Patients should be monitored regularly for blood counts, liver enzymes, and respiratory symptoms, and any concerning signs should prompt immediate medical evaluation.
Who should not use Methotrexaat Accord?+
Methotrexaat Accord should be avoided in patients with severe renal or hepatic impairment, active uncontrolled infections, known hypersensitivity to methotrexate or its excipients, and in women who are pregnant or planning pregnancy without effective contraception. Clinicians must assess each individual’s risk before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Intraarterial Use , Intramuscular Use , Intratheca
Manufacturer
Accord Healthcare B.V.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU